Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2020

Feb 11, 2020

31799_dirs_2020-02-11_8acc4bd6-0725-4456-a105-4c445a9de047.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2020-02-11

Reporting Person: Hopper Jonathan Mark (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2426 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $16.66 2029-02-06 Common Stock (24375) Direct
Stock Option (right to buy) $10.95 2028-08-20 Common Stock (36528) Direct
Stock Option (right to buy) $10.95 2028-08-20 Common Stock (98472) Direct
Stock Option (right to buy) $16.66 2029-02-06 Common Stock (1625) Direct
Restricted Stock Unit $ Common Stock (1950) Direct

Footnotes

F1: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

F2: 25% of these options will vest on the first anniversary of the date of grant and 75% will vest in equal quarterly installments over three years thereafter.

F3: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

F4: These RSUs vest in four annual installments. The first installment of RSUs vested on February 6, 2020 and are shown in the holdings reported in Table I. The remaining 1,950 RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively.

F5: No expiration date for this type of award.